Impact of PD-1+Tim-3+CD8+ T cells in pretreatment tumors on chemotherapy responses in esophageal cancer.

Saved in:
Bibliographic Details
Title: Impact of PD-1+Tim-3+CD8+ T cells in pretreatment tumors on chemotherapy responses in esophageal cancer.
Authors: Sumimoto T; Department of Gastroenterological Surgery, Graduate School of Medicine, The University of Osaka, 2-2-E2, Yamada-oka, Suita, Osaka, 565-0871, Japan.; Department of Clinical Research in Tumor Immunology, Graduate School of Medicine, The University of Osaka, 2-2-0803B, Yamada-oka, Suita, Osaka, 565-0871, Japan., Yamamoto K; Department of Gastroenterological Surgery, Graduate School of Medicine, The University of Osaka, 2-2-E2, Yamada-oka, Suita, Osaka, 565-0871, Japan.; Department of Clinical Research in Tumor Immunology, Graduate School of Medicine, The University of Osaka, 2-2-0803B, Yamada-oka, Suita, Osaka, 565-0871, Japan., Saito T; Department of Gastroenterological Surgery, Graduate School of Medicine, The University of Osaka, 2-2-E2, Yamada-oka, Suita, Osaka, 565-0871, Japan. saitou.takurou.med@osaka-u.ac.jp.; Department of Clinical Research in Tumor Immunology, Graduate School of Medicine, The University of Osaka, 2-2-0803B, Yamada-oka, Suita, Osaka, 565-0871, Japan. saitou.takurou.med@osaka-u.ac.jp., Urakawa S; Department of Gastroenterological Surgery, Graduate School of Medicine, The University of Osaka, 2-2-E2, Yamada-oka, Suita, Osaka, 565-0871, Japan.; Department of Clinical Research in Tumor Immunology, Graduate School of Medicine, The University of Osaka, 2-2-0803B, Yamada-oka, Suita, Osaka, 565-0871, Japan., Takeoka T; Department of Gastroenterological Surgery, Graduate School of Medicine, The University of Osaka, 2-2-E2, Yamada-oka, Suita, Osaka, 565-0871, Japan.; Department of Clinical Research in Tumor Immunology, Graduate School of Medicine, The University of Osaka, 2-2-0803B, Yamada-oka, Suita, Osaka, 565-0871, Japan., Makino T; Department of Gastroenterological Surgery, Graduate School of Medicine, The University of Osaka, 2-2-E2, Yamada-oka, Suita, Osaka, 565-0871, Japan., Kurokawa Y; Department of Gastroenterological Surgery, Graduate School of Medicine, The University of Osaka, 2-2-E2, Yamada-oka, Suita, Osaka, 565-0871, Japan., Kawashima A; Department of Urology, Graduate School of Medicine, The University of Osaka, 2-2, Yamada-oka, Suita, Osaka, 565-0871, Japan., Ueyama A; Department of Clinical Research in Tumor Immunology, Graduate School of Medicine, The University of Osaka, 2-2-0803B, Yamada-oka, Suita, Osaka, 565-0871, Japan.; Drug Discovery & Disease Research Laboratory, Shionogi & Co., Ltd, Toyonaka, Japan., Eguchi H; Department of Gastroenterological Surgery, Graduate School of Medicine, The University of Osaka, 2-2-E2, Yamada-oka, Suita, Osaka, 565-0871, Japan., Doki Y; Department of Gastroenterological Surgery, Graduate School of Medicine, The University of Osaka, 2-2-E2, Yamada-oka, Suita, Osaka, 565-0871, Japan., Wada H; Department of Clinical Research in Tumor Immunology, Graduate School of Medicine, The University of Osaka, 2-2-0803B, Yamada-oka, Suita, Osaka, 565-0871, Japan.
Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2026 Jun 18. Date of Electronic Publication: 2026 Jun 18.
Publication Type: Journal Article
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1432-0851
DOI:10.1007/s00262-026-04303-4